These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 10368279)

  • 21. Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1.
    Aertgeerts K; De Bondt HL; De Ranter CJ; Declerck PJ
    Nat Struct Biol; 1995 Oct; 2(10):891-7. PubMed ID: 7552714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding.
    Wind T; Jensen MA; Andreasen PA
    Eur J Biochem; 2001 Feb; 268(4):1095-106. PubMed ID: 11179976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis for serpin inhibitor activity.
    Wright HT; Scarsdale JN
    Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
    Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
    Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1.
    Li SH; Reinke AA; Sanders KL; Emal CD; Whisstock JC; Stuckey JA; Lawrence DA
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4941-9. PubMed ID: 24297881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
    Egelund R; Petersen TE; Andreasen PA
    Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divining the serpin inhibition mechanism: a suicide substrate 'springe'?
    Engh RA; Huber R; Bode W; Schulze AJ
    Trends Biotechnol; 1995 Dec; 13(12):503-10. PubMed ID: 8595135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
    Kvassman JO; Verhamme I; Shore JD
    Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q; Shaltiel S
    BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of helix F in plasminogen activator inhibitor-1.
    Vleugels N; Gils A; Bijnens AP; Knockaert I; Declerck PJ
    Biochim Biophys Acta; 2000 Jan; 1476(1):20-6. PubMed ID: 10606763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization.
    Egelund R; Einholm AP; Pedersen KE; Nielsen RW; Christensen A; Deinum J; Andreasen PA
    J Biol Chem; 2001 Apr; 276(16):13077-86. PubMed ID: 11278457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
    Schroeck F; Arroyo de Prada N; Sperl S; Schmitt M; Viktor M
    Biol Chem; 2002; 383(7-8):1143-9. PubMed ID: 12437099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis.
    Izuhara Y; Takahashi S; Nangaku M; Takizawa S; Ishida H; Kurokawa K; van Ypersele de Strihou C; Hirayama N; Miyata T
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):672-7. PubMed ID: 18239154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural factors affecting the choice between latency transition and polymerization in inhibitory serpins.
    Yi JY; Im H
    Protein Sci; 2007 May; 16(5):833-41. PubMed ID: 17400919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of stabilizing versus destabilizing interactions on plasminogen activator inhibitor-1.
    Vleugels N; Leys J; Knockaert I; Declerck PJ
    J Pharm Belg; 2000; 55(2):57-8. PubMed ID: 10842928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insight into inactivation of plasminogen activator inhibitor-1 by a small-molecule antagonist.
    Lin Z; Jensen JK; Hong Z; Shi X; Hu L; Andreasen PA; Huang M
    Chem Biol; 2013 Feb; 20(2):253-61. PubMed ID: 23438754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-resolution structure of the stable plasminogen activator inhibitor type-1 variant 14-1B in its proteinase-cleaved form: a new tool for detailed interaction studies and modeling.
    Jensen JK; Gettins PG
    Protein Sci; 2008 Oct; 17(10):1844-9. PubMed ID: 18725454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.
    Stefansson S; Lawrence DA
    Nature; 1996 Oct; 383(6599):441-3. PubMed ID: 8837777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1.
    Einholm AP; Pedersen KE; Wind T; Kulig P; Overgaard MT; Jensen JK; Bødker JS; Christensen A; Charlton P; Andreasen PA
    Biochem J; 2003 Aug; 373(Pt 3):723-32. PubMed ID: 12723974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.